← Back to Clinical Trials
Recruiting NCT07043569

NCT07043569 Clinical-randomized Trial of the Effect of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Anterior Cruciate Ligament Reconstruction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07043569
Status Recruiting
Phase
Sponsor University Hospital, Bonn
Condition ACL - Anterior Cruciate Ligament Rupture
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-06-20
Primary Completion 2026-07-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Resistance Training with Sham-BFRResistance Exercise with BFR

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-06-20 with a primary completion date of 2026-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

With the intention of improving rehabilitation after anterior cruciate ligament reconstruction, the present project investigates the influence of a targeted strength and blood flow restriction training intervention (BFR training) on the regeneration of muscle mass, strength and functionality of the knee joint. BFR training is characterized by the combination of external venous vascular occlusion with light strength training and still enables users to achieve gains in muscle mass and strength that are comparable to training with high mechanical loads. The positive effects of BFR training in the course of knee arthroplasty have already been demonstrated by our working group as a prehabilitative approach, i.e. as a training intervention prior to surgery. In the present project, the framework conditions of outpatient rehabilitation at the Bonn Center for Outpatient Rehabilitation will now be used to prove whether sports science-controlled strength and BFR training has a similar effect in the postoperative rehabilitation phase. The interventions are carried out as part of the exercise therapy units in outpatient rehabilitation ETM01 in accordance with the S2k guideline on anterior cruciate ligament rupture. Strength and BFR training in medical training therapy supplements the daily exercise therapy to ensure implementation in the rehabilitation process in line with the guidelines.

Eligibility Criteria

Inclusion Criteria: * ACL reconstruction * Ability to take part in an outpatient rehabilitation Exclusion Criteria: * Sickle Cell anemia * iatrogenic changes in the vessels of the lower limbs (stents, bypasses) * inflammation of the lower extremities

Contact & Investigator

Central Contact

Alexander Franz, Dr. med., B.Sc.

✉ alexander.franz@ukbonn.de

📞 +491703750718

Frequently Asked Questions

Who can join the NCT07043569 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying ACL - Anterior Cruciate Ligament Rupture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07043569 currently recruiting?

Yes, NCT07043569 is actively recruiting participants. Contact the research team at alexander.franz@ukbonn.de for enrollment information.

Where is the NCT07043569 trial being conducted?

This trial is being conducted at Bonn, Germany.

Who is sponsoring the NCT07043569 clinical trial?

NCT07043569 is sponsored by University Hospital, Bonn. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology